ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109451; 2) Community: the network communities that were significantly associated with the response to NSC 109451; 3) Molecule: the relationships between components within communities and NSC 109451; 4) MDR: the compounds that were significantly associated with the NSC 109451.

NSC Compound Enrichment Correlation
NSC 701100 2H-1-Benzopyran-2-one, 6-chloro-3-[imidazo[1,2-a]pyridin-2-yl]- 0.0283958753782626 0.50252754
NSC 709928 Null 0.0283958753782626 0.59033474
NSC 736049 N-[2-(4-methoxyphenyl)-4-oxo-1,3-thiazolidin-3-yl]-N'-(2-met hylimidazo[1,2-a]pyridin-3-yl)urea 0.0283958753782626 0.6438472
NSC 740275 5,6-Dihydro-6-(3-morpholinyl-1-propyl)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0283958753782626 0.53562624
NSC 752384 Null 0.0287230216965523 0.58204819
NSC 763582 Null 0.0287230216965523 0.42758058
NSC 123140 Alanine, 3-[(.alpha.,.alpha.-di-p-tolylbenzyl)thio]- 0.030556149892922 0.061387265
NSC 136036 Pentalenolactone 0.030556149892922 0.034498679
NSC 226080 Sirolimus 0.030556149892922 0.34420593
NSC 271967 Methanaminium, N-[4-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, 1,2-benzenedicarboxylate (1:1) 0.030556149892922 -0.040994476
Total:114  Current:73    [First] [Prev] [Next] [Last]